The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin
Abstract
Objectives: The oxazolidinone-resistant Enterococcus faecalis E349 from a human patient tested negative for the cfr gene and 23S rRNA mutations. Here we report the identification of a novel oxazolidinone resistance gene, optrA, and a first investigation of the extent to which this gene was present in E. faecalis and Enterococcus faecium from humans and food-producing animals. Methods: The resistance gene optrA was identified by whole-plasmid sequencing and subsequent cloning and expression in a susceptible Enterococcus host. Transformation and conjugation assays served to investigate the transferability of optrA. All optrA-positive E. faecalis and E. faecium isolates of human and animal origin were analysed for their MICs and their genotype, as well as the location of optrA. Results: The novel plasmid-borne ABC transporter gene optrA from E. faecalis E349 conferred combined resistance or elevated MICs (when no clinical breakpoints were available) to oxazolidinones (linezolid and tedizolid) and phenicols (chloramphenicol and florfenicol). The corresponding conjugative plasmid pE349, on which optrA was located, had a size of 36 331 bp and also carried the phenicol exporter gene fexA. The optrA gene was functionally expressed in E. faecalis, E. faecium and Staphylococcus aureus. It was detected more frequently in E. faecalis and E. faecium from food-producing animals (20.3% and 5.7%, respectively) than from humans (4.2% and 0.6%, respectively). Conclusions: Enterococci with elevated MICs of linezolid and tedizolid should be tested not only for 23S rRNA mutations and the gene cfr, but also for the novel resistance gene optrA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
The antibiotic resistome: the nexus of chemical and genetic diversity
Wright, G. D. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1614 · Cited by 1,365
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Self-citationNoble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542
Emergence and spread of vancomycin resistance among enterococci in Europe
Werner, G., Coque, T. M., Hammerum, A. M., Hope, R., Hryniewicz, W., Johnson, A., Klare, I., Kristinsson, K. G., Leclercq, R., Lester, C. H., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19046-en · Cited by 539
Schneider, E. (1998) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(98)00002-3 · Cited by 514
Relationships between Enterococcal Virulence and Antimicrobial Resistance
Mundy, L. M., Sahm, D. F., & Gilmore, M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.513 · Cited by 500
Oxazolidinones: activity, mode of action, and mechanism of resistance
Bozdogan, B., & Appelbaum, P. C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.11.003 · Cited by 403
Leavis, H. L., Bonten, M. J., & Willems, R. J. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.07.001 · Cited by 325
Emergence and management of drug-resistant enterococcal infections
Arias, C. A., & Murray, B. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.637 · Cited by 294
Enterococci of animal origin and their significance for public health
Hammerum, A. M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03829.x · Cited by 283
Shen, J., Wang, Y., & Schwarz, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt092 · Cited by 258
Self-citationProduction of l-DOPA by Aspergillus terreus
Chattopadhyay, S., & Das, A. (1990) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1990.tb03888.x · Cited by 243
Nosocomial Spread of Linezolid-Resistant, Vancomycin-Resistant Enterococcus faecium
Herrero, I. A., Issa, N. C., & Patel, R. (2002) · New England Journal of Medicine · doi:10.1056/nejm200203143461121 · Cited by 241
Rahim, S., Pillai, S. K., Gold, H. S., Venkataraman, L., Inglima, K., & Press, R. A. (2003) · Clinical Infectious Diseases · doi:10.1086/374929 · Cited by 129
Tedizolid for the Management of Human Infections: In Vitro Characteristics
Locke, J. B., Zurenko, G. E., Shaw, K. J., & Bartizal, K. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit616 · Cited by 101
Liu, Y., Wang, Y., Schwarz, Š., Li, Y., Shen, Z., Zhang, Q., Wu, C., & Shen, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01605-12 · Cited by 101
Self-citationWendlandt, S., Lozano, C., Kadlec, K., Gómez-Sanz, E., Zarazaga, M., Torres, C., & Schwarz, Š. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks398 · Cited by 96
Wendlandt, S., Shen, J., Kadlec, K., Wang, Y., Li, B., Zhang, W.-J., Feßler, A. T., Wu, C., & Schwarz, Š. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.10.002 · Cited by 92
Self-citationSubbiah, M., Mitchell, S. M., Ullman, J. L., & Call, D. R. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05352-11 · Cited by 92
Dose Dependence of Emergence of Resistance to Linezolid inEnterococcus faecalisIn Vivo
Bourgeois‐Nicolaos, N., Massias, L., Couson, B., Butel, M., Andremont, A., & Doucet‐Populaire, F. (2007) · The Journal of Infectious Diseases · doi:10.1086/513876 · Cited by 83
Cited by
Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 845
The Enterococcus: a Model of Adaptability to Its Environment
García-Solache, M., & Rice, L. B. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-18 · Cited by 754
Linezolid: a review of its properties, function, and use in critical care
Hashemian, S. M., Farhadi, T., & Ganjparvar, M. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s164515 · Cited by 459
Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?
Guzman Prieto, A. M., van Schaik, W., Rogers, M. R. C., Coque, T. M., Baquero, F., Corander, J., & Willems, R. J. L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00788 · Cited by 385
Munk, P., Knudsen, B. E., Lukjancenko, O., Duarte, A. S. R., Van Gompel, L., Luiken, R. E. C., Smit, L. A. M., Schmitt, H., Garcia, A. D., Hansen, R. B., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0192-9 · Cited by 355
Metadata
- Authors
- Wang, Y., Lv, Y., Cai, J., Schwarz, S., Cui, L., Hu, Z., Zhang, R., Li, J., Zhao, Q., He, T., Wang, D., Wang, Z., Shen, Y., Li, Y., Feßler, A. T., Wu, C., Yu, H., Deng, X., Xia, X., & Shen, J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-05-14
- Volume
- 70
- Issue
- 8
- Pages
- 2182-2190
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2298195942
- Cited by
- 546
- References
- 23
- FWCI
- 14.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.